Cargando…
Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana
Background: HIV-1 drug resistance poses a major threat to the success of antiretroviral therapy. The high costs of available HIV drug resistance assays prohibit their routine usage in resource-limited settings. Pan-degenerate amplification and adaptation (PANDAA), a focused genotyping approach based...
Autores principales: | Maruapula, Dorcas, MacLeod, Iain J., Moyo, Sikhulile, Musonda, Rosemary, Seatla, Kaelo, Molebatsi, Kesaobaka, Leteane, Melvin, Essex, Max, Gaseitsiwe, Simani, Rowley, Christopher F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112461/ https://www.ncbi.nlm.nih.gov/pubmed/34036243 http://dx.doi.org/10.12688/aasopenres.13107.2 |
Ejemplares similares
-
Limited HIV-1 Subtype C nef 3′PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana
por: Seatla, Kaelo K., et al.
Publicado: (2021) -
Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2020) -
Comparison of an in-house ‘home-brew’ and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples
por: Seatla, Kaelo K., et al.
Publicado: (2019) -
Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018) -
Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018)